|
|
 Previous Article | Table of Contents | Next Article 
A retinoid-resistant acute promyelocytic leukemia subclone expresses a
dominant negative PML-RAR alpha mutation
W Shao, L Benedetti, WW Lamph, C Nervi and WH Miller
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish
General Hospital and McGill University Department of Oncology, Montreal,
Quebec, Canada.
The unique t(15;17) of acute promyelocytic leukemia (APL) fuses the PML
gene with the retinoic acid receptor alpha (RAR alpha) gene. Although
retinoic acid (RA) inhibits cell growth and induces differentiation in
human APL cells, resistance to RA develops both in vitro and in patients.
We have developed RA-resistant subclones of the human APL cell line, NB4,
whose nuclear extracts display altered RA binding. In the RA-resistant
subclone, R4, we find an absence of ligand binding of PML-RAR alpha
associated with a point mutation changing a leucine to proline in the
ligand-binding domain of the fusion PML-RAR alpha protein. In contrast to
mutations in RAR alpha found in retinoid- resistant HL60 cells, in this NB4
subclone, the coexpressed RAR alpha remains wild-type. In vitro expression
of a cloned PML-RAR alpha with the observed mutation in R4 confirms that
this amino acid change causes the loss of ligand binding, but the mutant
PML-RAR alpha protein retains the ability to heterodimerize with RXR alpha
and thus to bind to retinoid response elements (RAREs). This leads to a
dominant negative block of transcription from RAREs that is dose-dependent
and not relieved by RA. An unrearranged RAR alpha engineered with this
mutation also lost ligand binding and inhibited transcription in a dominant
negative manner. We then found that the mutant PML-RAR alpha selectively
alters regulation of gene expression in the R4 cell line. R4 cells have
lost retinoid-regulation of RXR alpha and RAR beta and the RA-induced loss
of PML-RAR alpha protein seen in NB4 cells, but retain retinoid-induction
of CD18 and CD38. Thus, the R4 cell line provides data supporting the
presence of an RAR alpha-mediated pathway that is independent from gene
expression induced or repressed by PML- RAR alpha. The high level of
retinoid resistance in vitro and in vivo of cells from some relapsed APL
patients suggests similar molecular changes may occur clinically.
Volume 89,
Issue 12,
pp. 4282-4289,
06/15/1997
Copyright © 1997 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. H. Lin, E. J. Kim, A. Bansal, J. Seykora, S. K. Richardson, X.-Y. Cha, S. Zafar, S. Nasta, M. Wysocka, B. Benoit, et al.
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-{alpha} receptor
Blood,
September 15, 2008;
112(6):
2484 - 2488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. McNamara, H. Wang, N. Hanna, and W. H. Miller Jr.
Topoisomerase II{beta} Negatively Modulates Retinoic Acid Receptor {alpha} Function: a Novel Mechanism of Retinoic Acid Resistance
Mol. Cell. Biol.,
March 15, 2008;
28(6):
2066 - 2077.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. P. Ng, D. S. Nin, J. H. Fong, D. Venkataraman, C.-S. Chen, and M. Khan
Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein
Mol. Cancer Ther.,
August 1, 2007;
6(8):
2240 - 2248.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-g. Wang, L. W. Barsky, E. Davicioni, K. I. Weinberg, T. J. Triche, X.-k. Zhang, and L. Wu
Retinoic acid induces leukemia cell G1 arrest and transition into differentiation by inhibiting cyclin-dependent kinase-activating kinase binding and phosphorylation of PML/RAR{alpha}
FASEB J,
October 1, 2006;
20(12):
2142 - 2144.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Passeri, A. Marcucci, G. Rizzo, M. Billi, M. Panigada, L. Leonardi, F. Tirone, and F. Grignani
Btg2 enhances retinoic Acid-induced differentiation by modulating histone h4 methylation and acetylation.
Mol. Cell. Biol.,
July 1, 2006;
26(13):
5023 - 5032.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Matsushita, P. P. Scaglioni, M. Bhaumik, E. M. Rego, L. F. Cai, S. M. Majid, H. Miyachi, A. Kakizuka, W. H. Miller Jr., and P. P. Pandolfi
In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR{alpha} blockade in the pathogenesis of acute promyelocytic leukemia
J. Exp. Med.,
April 17, 2006;
203(4):
821 - 828.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Witcher, H. Y. Shiu, Q. Guo, and W. H. Miller Jr
Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells
Blood,
November 15, 2004;
104(10):
3335 - 3342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Davison, K. K. Mann, S. Waxman, and W. H. Miller Jr
JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells
Blood,
May 1, 2004;
103(9):
3496 - 3502.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Kamashev, D. Vitoux, and H. de The
PML-RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation
J. Exp. Med.,
April 19, 2004;
199(8):
1163 - 1174.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Mann, A. Rephaeli, A. L. Colosimo, Z. Diaz, A. Nudelman, I. Levovich, Y. Jing, S. Waxman, and W. H. Miller Jr.
A Retinoid/Butyric Acid Prodrug Overcomes Retinoic Acid Resistance in Leukemias by Induction of Apoptosis
Mol. Cancer Res.,
October 1, 2003;
1(12):
903 - 912.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Farboud, H. Hauksdottir, Y. Wu, and M. L. Privalsky
Isotype-Restricted Corepressor Recruitment: a Constitutively Closed Helix 12 Conformation in Retinoic Acid Receptors {beta} and {gamma} Interferes with Corepressor Recruitment and Prevents Transcriptional Repression
Mol. Cell. Biol.,
April 15, 2003;
23(8):
2844 - 2858.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Cote, A. Rosenauer, A. Bianchini, K. Seiter, J. Vandewiele, C. Nervi, and W. H. Miller Jr
Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells
Blood,
September 18, 2002;
100(7):
2586 - 2596.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Dong and D. J. Tweardy
Interactions of STAT5b-RARalpha , a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways
Blood,
April 15, 2002;
99(8):
2637 - 2646.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Murate, M. Suzuki, M. Hattori, A. Takagi, T. Kojima, T. Tanizawa, H. Asano, T. Hotta, H. Saito, S. Yoshida, et al.
Up-regulation of Acid Sphingomyelinase during Retinoic Acid-induced Myeloid Differentiation of NB4, a Human Acute Promyelocytic Leukemia Cell Line
J. Biol. Chem.,
March 15, 2002;
277(12):
9936 - 9943.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Kogan, D. E. Brown, D. B. Shultz, B.-T. H. Truong, V. Lallemand-Breitenbach, M.-C. Guillemin, E. Lagasse, I. L. Weissman, and J. M. Bishop
BCL-2 Cooperates with Promyelocytic Leukemia Retinoic Acid Receptor {{alpha}} Chimeric Protein (PMLRAR{{alpha}}) to Block Neutrophil Differentiation and Initiate Acute Leukemia
J. Exp. Med.,
February 20, 2001;
193(4):
531 - 544.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Idres, G. Benoît, M. A. Flexor, M. Lanotte, and G. G. Chabot
Granulocytic Differentiation of Human NB4 Promyelocytic Leukemia Cells Induced by All-trans Retinoic Acid Metabolites
Cancer Res.,
January 1, 2001;
61(2):
700 - 705.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H. Wang, X. Zheng, F. G. Behm, and M. Ratnam
Differentiation-independent retinoid induction of folate receptor type beta , a potential tumor target in myeloid leukemia
Blood,
November 15, 2000;
96(10):
3529 - 3536.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ikezoe, E. S. Daar, J.-i. Hisatake, H. Taguchi, and H. P. Koeffler
HIV-1 protease inhibitors decrease proliferation and induce differentiation of human myelocytic leukemia cells
Blood,
November 15, 2000;
96(10):
3553 - 3559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Cote, D. Zhou, A. Bianchini, C. Nervi, R. E. Gallagher, and W. H. Miller Jr
Altered ligand binding and transcriptional regulation by mutations in the PML/RARalpha ligand-binding domain arising in retinoic acid-resistant patients with acute promyelocytic leukemia
Blood,
November 1, 2000;
96(9):
3200 - 3208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gambacorti-Passerini, R. Barni, P. le Coutre, M. Zucchetti, G. Cabrita, L. Cleris, F. Rossi, E. Gianazza, J. Brueggen, R. Cozens, et al.
Role of {alpha}1 Acid Glycoprotein in the In Vivo Resistance of Human BCR-ABL+ Leukemic Cells to the Abl Inhibitor STI571
J Natl Cancer Inst,
October 18, 2000;
92(20):
1641 - 1650.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Shao, A. Rosenauer, K. Mann, C.-P. B. Chang, C. Rachez, L. P. Freedman, and W. H. Miller Jr
Ligand-inducible interaction of the DRIP/TRAP coactivator complex with retinoid receptors in retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells
Blood,
September 15, 2000;
96(6):
2233 - 2239.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. C. Kogan, S.-h. Hong, D. B. Shultz, M. L. Privalsky, and J. M. Bishop
Leukemia initiated by PMLRARalpha : the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable
Blood,
March 1, 2000;
95(5):
1541 - 1550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zhu, M. Gianni, E. Kopf, N. Honore, M. Chelbi-Alix, M. Koken, F. Quignon, C. Rochette-Egly, and H. de The
Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha ) and oncogenic RARalpha fusion proteins
PNAS,
December 21, 1999;
96(26):
14807 - 14812.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Jing, J. Dai, R. M.E. Chalmers-Redman, W. G. Tatton, and S. Waxman
Arsenic Trioxide Selectively Induces Acute Promyelocytic Leukemia Cell Apoptosis Via a Hydrogen Peroxide-Dependent Pathway
Blood,
September 15, 1999;
94(6):
2102 - 2111.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Naoe, K. Kitamura;, M. Fanelli, and P. G. Pelicci
Relationship Between Degradation of PML-RARalpha and Differentiation
Blood,
August 15, 1999;
94(4):
1478 - 1479.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Melnick and J. D. Licht
Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia
Blood,
May 15, 1999;
93(10):
3167 - 3215.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Fanelli, S. Minucci, V. Gelmetti, C. Nervi, C. Gambacorti-Passerini, and P. G. Pelicci
Constitutive Degradation of PML/RARalpha Through the Proteasome Pathway Mediates Retinoic Acid Resistance
Blood,
March 1, 1999;
93(5):
1477 - 1481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Muller, W. H. Miller Jr, and A. Dejean
Trivalent Antimonials Induce Degradation of the PML-RARalpha Oncoprotein and Reorganization of the Promyelocytic Leukemia Nuclear Bodies in Acute Promyelocytic Leukemia NB4 Cells
Blood,
December 1, 1998;
92(11):
4308 - 4316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Nervi, F. F. Ferrara, M. Fanelli, M. R. Rippo, B. Tomassini, P. F. Ferrucci, M. Ruthardt, V. Gelmetti, C. Gambacorti-Passerini, D. Diverio, et al.
Caspases Mediate Retinoic Acid-Induced Degradation of the Acute Promyelocytic Leukemia PML/RARalpha Fusion Protein
Blood,
October 1, 1998;
92(7):
2244 - 2251.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nason-Burchenal, J. Allopenna, A. Begue, D. Stehelin, E. Dmitrovsky, and P. Martin
Targeting of PML/RARalpha Is Lethal to Retinoic Acid-Resistant Promyelocytic Leukemia Cells
Blood,
September 1, 1998;
92(5):
1758 - 1767.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Ding, Y.-P. Li, L. M. Nobile, G. Grills, I. Carrera, E. Paietta, M. S. Tallman, P. H. Wiernik, and R. E. Gallagher
Leukemic Cellular Retinoic Acid Resistance and Missense Mutations in the PML-RARalpha Fusion Gene After Relapse of Acute Promyelocytic Leukemia From Treatment With All-trans Retinoic Acid and Intensive Chemotherapy
Blood,
August 15, 1998;
92(4):
1172 - 1183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Imaizumi, H. Suzuki, M. Yoshinari, A. Sato, T. Saito, A. Sugawara, S. Tsuchiya, Y. Hatae, T. Fujimoto, A. Kakizuka, et al.
Mutations in the E-Domain of RARalpha Portion of the PML/RARalpha Chimeric Gene May Confer Clinical Resistance to All-trans Retinoic Acid in Acute Promyelocytic Leukemia
Blood,
July 15, 1998;
92(2):
374 - 382.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.J. LIN, H.-Y. KAO, P. ORDENTLICH, and R.M. EVANS
The Transcriptional Basis of Steroid Physiology
Cold Spring Harb Symp Quant Biol,
January 1, 1998;
63(0):
577 - 586.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Y. Monczak, M. Trudel, W. W. Lamph, and W. H. Miller Jr
Induction of Apoptosis Without Differentiation by Retinoic Acid in PLB-985 Cells Requires the Activation of Both RAR and RXR
Blood,
November 1, 1997;
90(9):
3345 - 3355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
